Implantation of occlusion devices is an effective approach for the treatment of congenital
heart diseases in the clinic. However, most commercial clinical occlusion devices are …

Transcatheter closure has been widely accepted as a highly effective way to treat abnormal
blood flows and/or embolization of thrombus in the heart. It allows the closure of four types of …

Atrial septal defect (ASD) is a common structural congenital heart disease. With the
development of interventional closure devices and transcatheter techniques, interventional …

We would like to thank Son et al.[1] for their interest in our study [2]. We agree that there is a
paucity of suitable animal models for closure of muscular ventricular septal defects (VSDs) in …

Percutaneous closure of ventricular septal defect (VSD) can effectively occlude abnormal
blood flow between ventricles. However, commonly used Nitinol occlusion devices have non …

Objective To fabricate a biodegradable occluder for heart defect using the three-dimensional
(3D) printing technique and evaluate its biosafety in an animal model. Methods Occluder …

Objective To evaluate the feasibility, efficacy, and safety of a fully biodegradable poly lactic
acid (PLA)‐based occluder for atrial septal defect (ASD) closure in an animal model …

Cardiac septal defect is the most prevalent congenital heart disease and is typically treated
with open‐heart surgery under cardiopulmonary bypass. Since the 1990s, with the …

OBJECTIVES The feasibility of an Amplatzer septal occluder closure of ventricular septal
defects (VSDs) under echocardiographic guidance has already been proven. However, the …

Atrial septal defects (ASDs) are the most common types of cardiac septal defects in
congenital heart defects. In addition to traditional therapy, interventional closure has become …